Advertisement
Advertisement
BAX
Baxter International Inc.
25.81
USDSponsored
+0.07
+0.27%
Nov 13, 15:59 UTC -5
Closed
After-Market
25.51
-0.30
-1.16%
Baxter International Inc. (BAX) Earnings
BAX Earnings Reports
Positive Surprise Ratio
BAX beat 35 of 43 last estimates.
81%
Next Report
Date of Next Report
Feb 10, 2027
Estimate for Q4 26 (Revenue/ EPS)
$3.12B
/$0.60
Implied change from Q3 26 (Revenue/ EPS)
+4.76%
/+5.26%
Implied change from Q4 25 (Revenue/ EPS)
+4.83%
/+36.36%
Baxter International Inc. earnings per share and revenue
On Oct 29, 2026, BAX reported earnings of 0.57 USD per share (EPS) for Q3 26, beating the estimate of 0.52 USD, resulting in a 10.86% surprise. Revenue reached 2.98 billion, compared to an expected 2.94 billion, with a 1.32% difference. The market reacted with a -7.70% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.60 USD, with revenue projected to reach 3.12 billion USD, implying an increase of 5.26% EPS, and increase of 4.76% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.18
Actual
$0.26
Surprise
+39.63%
InMode Ltd. Ordinary Shares
Report Date
Nov 11, 2026 For Q3 26
Estimate
$0.32
Actual
$0.37
Surprise
+12.29%
Capricor Therapeutics Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.44
Actual
-$0.73
Surprise
-65.16%
Brainsway Ltd. - ADR
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.15
Surprise
-29.11%
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
$0.12
Surprise
+96.08%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-14.85%
Exagen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.25
Surprise
-35.35%
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Baxter International Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Baxter International Inc. reported EPS of $0.57, beating estimates by 10.86%, and revenue of $2.98B, 1.32% above expectations.
How did the market react to Baxter International Inc.'s Q3 2026 earnings?
The stock price moved down -7.7%, changed from $25.46 before the earnings release to $23.50 the day after.
When is Baxter International Inc. expected to report next?
The next earning report is scheduled for Feb 10, 2027.
What are the forecasts for Baxter International Inc.'s next earnings report?
Based on --
analysts, Baxter International Inc. is expected to report EPS of $0.60 and revenue of $3.12B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.